| Industry: | Venture Capital & Private Equity |
| Monthly Unique Visitors: |
891
|
| Site Rank: |
1,179,967
|
| Trust Rating: |
Neutral
|
Stats
by ![]() |
|
| Cerulean Pharma Inc. Closes $10 Million Series B-1 Financing. Business Wire; 7/28/2009 ...Partners of Waltham, MA, Venrock of New York, NY, Lux Capital of New York, NY, and Bessemer Venture Partners of Wellesley...leading investors Polaris Venture Partners, Venrock, Lux Capital, Bessemer Venture Partners, Alexandria Real Estate... ...more |
| BusinessWeek Names Genocea Biosciences One of the World's Most Intriguing Startups. Vaccine Weekly; 12/2/2009 ...Genocea is backed by leading investors including Lux Capital Management, Polaris Venture Partners, SR One, Auriga...FierceBiotech. Genocea is backed by leading investors including Lux Capital Management, Polaris Venture Partners, SR One, Auriga... ...more |
| BusinessWeek Salutes Genocea Biosciences as One of the World's Most Intriguing Startups Wireless News; 11/18/2009 ...and eradicate some of the world's most deadly and infectious diseases." Genocea is backed by investors including Lux Capital Management, Polaris Venture Partners, SR One, Auriga Partners, Cycad Group, Morningside Ventures and Alexandria... ...more |


| Revenue: | $3.2 Million |
| Employees: | 29 |



![]() |
Add New Company | Add Your Profile | Tools & Resources | Developer API | Sales & Marketing Blog
FAQ | Privacy Policy | Terms of Service | About Us | Contact Us | Jobs at ZoomInfo
Copyright © 2009 Zoom Information Inc. All rights reserved.
BBeachHead-2009-12-03_RC001.1 OM14